| 5 min read
From an executive order to lower drug prices to GLP-1 drug comparisons and a link between Parkinson’s disease and golf courses, it was a busy industry news week.
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 8 min read
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder.News
| 4 min read
During mold infection, a cytokine sends signals to neutrophils to kill invading fungal spores in the lungs, enhancing survival.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 9 min read
Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
| 4 min read
The therapy lengthened telomeres and improved immune function in people with telomere biology disorder, showing promise for treating bone marrow failure safely.
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
| 8 min read
Scientists are turning to breath samples as a way to detect tuberculosis economically and conveniently.
| 3 min read
A new antifungal drug, mandimycin, tackles resistant fungal strains with a never-before-seen mechanism that avoids kidney toxicity.
| 5 min read
What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.
| 4 min read
Landmark women’s health study loses funding, a promising antibody-drug conjugate for breast cancer, a schizophrenia drug setback, and more news from this week.
| 3 min read
The team at DropGenie uses digital microfluidics to perform gene editing screens on small numbers of patient cells, accelerating the discovery of new drugs.
| 4 min read
Scientists probed how tick proteins influenced host immunity, paving the way for mRNA vaccines to block Lyme and other tick-borne diseases.
| 6 min read
QurAlis researchers have developed QRL-101, a new drug candidate that targets overactive neurons to prevent cell death in ALS.
| 4 min read
Placental extracellular vesicles from maternal blood plasma identified women who would go on to develop complications later in their pregnancy.
| 5 min read
Stem cell therapy for Parkinson’s disease, discontinuation of Pfizer’s GLP-1 drug, a pig liver clinical trial, and more biotech and pharma news from this week.
Page 1 of 30 - 581 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
